Recommended Global Oncology & Cancer Webinars & Conferences
Europe & UK
Asia Pacific & Middle East
Canada
Cancer Research 2026
About conference
The 22nd International Conference on Cancer Research (Cancer Research 2026), scheduled for October 05–06, 2026, in Madrid, Spain, will serve as a premier international platform for scientists, oncologists, healthcare professionals, researchers, academicians, and industry leaders to exchange knowledge and discuss the latest developments in cancer research and oncology. The conference is designed to foster collaboration across multidisciplinary fields and promote innovative approaches to understanding, preventing, diagnosing, and treating cancer.
Centred on the theme "Revolutionizing Cancer Research: Integrating Genomics, Immunotherapy, and Precision Medicine," the conference will highlight cutting-edge discoveries that are transforming cancer care. Participants will explore advances in cancer genomics, molecular oncology, immuno-oncology, targeted therapies, biomarker development, liquid biopsy technologies, tumour microenvironment research, artificial intelligence in oncology, and personalized treatment strategies. The program will also address emerging trends in cancer prevention, early detection, translational research, clinical trials, and survivorship care.
Cancer Research 2026 will feature keynote presentations from internationally recognized experts, plenary lectures, scientific sessions, panel discussions, workshops, poster presentations, and networking opportunities. These sessions are designed to encourage scientific dialogue, foster partnerships, and facilitate the translation of laboratory discoveries into clinical applications that improve patient outcomes.
The conference provides an excellent opportunity for early-career researchers, students, clinicians, and industry representatives to showcase their work, gain insights into current challenges and future directions in oncology, and establish meaningful collaborations with peers from around the world. Exhibitors and sponsors will also have the opportunity to present innovative technologies, diagnostic tools, pharmaceuticals, and research solutions to a global audience.
By bringing together experts from academia, healthcare institutions, research organizations, and the biotechnology and pharmaceutical sectors, Cancer Research 2026 aims to accelerate scientific innovation and contribute to the advancement of effective, patient-centred cancer care worldwide. Through knowledge sharing and collaborative efforts, the conference seeks to support the global mission of reducing the burden of cancer and improving the quality of life for patients across diverse populations.
Session & tracks
Cancer biology focuses on understanding the fundamental mechanisms that drive cancer initiation, progression, and metastasis. Researchers investigate cellular signalling pathways, genetic alterations, tumour heterogeneity, and interactions within the tumour microenvironment to uncover the underlying causes of cancer development. Advances in molecular and cellular biology have significantly improved our understanding of how cancer cells evade normal growth controls and adapt to therapeutic interventions. This field plays a critical role in identifying novel biomarkers, therapeutic targets, and strategies for disease prevention and treatment. Ongoing research in cancer biology continues to provide valuable insights into tumour behaviour and supports the development of innovative therapies aimed at improving patient outcomes and advancing precision oncology.
Cancer genomics explores the genetic and epigenetic changes associated with cancer development and progression. High-throughput sequencing technologies have revolutionized the identification of mutations, gene expression patterns, and molecular signatures that influence tumour behaviour. Understanding the genomic landscape of cancer enables researchers to develop targeted therapies and personalized treatment approaches. This field also contributes to biomarker discovery, risk assessment, and disease monitoring. As genomic technologies become increasingly accessible, cancer genomics continues to drive advancements in precision medicine and improve clinical decision-making for patients with diverse cancer types.
Immunotherapy has transformed cancer treatment by harnessing the body's immune system to recognize and destroy cancer cells. This field includes immune checkpoint inhibitors, adoptive cell therapies, monoclonal antibodies, and cancer vaccines. Researchers are exploring ways to enhance immune responses, overcome treatment resistance, and expand the benefits of immunotherapy across a broader range of cancers. Continuous innovations in immuno-oncology are leading to more effective and durable treatment outcomes. The integration of immunotherapy into standard cancer care has significantly improved survival rates and opened new possibilities for personalized cancer treatment.
Precision oncology focuses on tailoring cancer treatment based on the unique genetic, molecular, and clinical characteristics of individual patients. By integrating genomic profiling, biomarker analysis, and advanced diagnostics, clinicians can select therapies that are most likely to benefit specific patient populations. This approach minimizes unnecessary treatments and enhances therapeutic effectiveness. Precision oncology represents a major shift from traditional treatment models toward personalized healthcare solutions. Ongoing research aims to refine predictive tools and expand access to precision-based interventions across various cancer types.
Cancer diagnostics encompasses the technologies and methodologies used to detect, classify, and monitor cancer. Advances in imaging, molecular testing, liquid biopsy, and biomarker analysis have improved the accuracy and speed of diagnosis. Early and precise detection is essential for effective treatment planning and improved patient outcomes. Researchers continue to develop innovative diagnostic tools that enhance disease monitoring and facilitate personalized therapeutic strategies. The field remains central to modern oncology, supporting both clinical care and cancer research initiatives.
Targeted therapy involves the use of drugs designed to interfere with specific molecular pathways that drive cancer growth and survival. Unlike conventional chemotherapy, targeted treatments aim to selectively attack cancer cells while minimizing damage to healthy tissues. Research in this field focuses on identifying new therapeutic targets, overcoming drug resistance, and optimizing treatment combinations. Advances in molecular oncology have accelerated the development of targeted therapies for a wide range of malignancies, contributing to improved efficacy and patient outcomes.
Clinical oncology focuses on the diagnosis, treatment, and management of cancer patients through evidence-based medical practice. This field integrates advances in medical oncology, radiation therapy, and supportive care to provide comprehensive treatment strategies. Clinical research plays a vital role in evaluating new therapies, improving treatment protocols, and enhancing patient quality of life. The continuous evolution of clinical oncology supports the translation of scientific discoveries into practical healthcare solutions and contributes to the advancement of cancer care worldwide.
Radiation oncology utilizes ionizing radiation to treat cancer and control tumour growth. Technological innovations in imaging, treatment planning, and radiation delivery have significantly enhanced precision and effectiveness. Modern radiotherapy techniques aim to maximize tumour control while minimizing side effects and preserving healthy tissue. Research in radiation oncology continues to explore novel treatment approaches, combination therapies, and personalized radiation strategies to improve clinical outcomes and patient safety.
Surgical oncology focuses on the surgical management of cancer and remains a cornerstone of cancer treatment. Advances in minimally invasive procedures, robotic-assisted surgery, and image-guided techniques have improved precision and recovery times. Surgical interventions are often combined with systemic therapies and radiation to achieve optimal treatment outcomes. Research in this field seeks to enhance surgical effectiveness, reduce complications, and improve long-term patient survival.
Cancer prevention aims to reduce the incidence of cancer through risk reduction strategies, public health initiatives, and early intervention programs. Research focuses on identifying environmental, genetic, and lifestyle factors that contribute to cancer development. Preventive measures such as vaccination, screening, and health education play a critical role in reducing cancer burden. Advances in prevention science continue to support evidence-based approaches that improve population health and decrease cancer-related mortality.
Translational research bridges the gap between laboratory discoveries and clinical applications. It focuses on transforming scientific findings into practical tools, diagnostics, and therapies that benefit patients. This interdisciplinary field promotes collaboration among researchers, clinicians, and industry partners to accelerate innovation and improve healthcare outcomes. Translational cancer research is essential for advancing personalized medicine and ensuring that scientific breakthroughs reach clinical practice efficiently.
Pediatric oncology addresses cancers affecting infants, children, and adolescents. Research in this field focuses on understanding the unique biological characteristics of childhood cancers and developing age-appropriate treatment strategies. Advances in genomics, targeted therapies, and supportive care have significantly improved survival rates. Continued efforts aim to reduce treatment-related complications and enhance long-term quality of life for Pediatric cancer survivors.
Cancer biomarkers are measurable biological indicators used for diagnosis, prognosis, treatment selection, and disease monitoring. Advances in molecular biology and genomics have expanded the discovery of novel biomarkers that support precision medicine. Biomarker research plays a crucial role in improving patient stratification, predicting therapeutic response, and identifying disease recurrence. This rapidly evolving field continues to drive innovation in cancer diagnostics and personalized treatment.
Cancer survivorship focuses on the long-term health and well-being of individuals living with and beyond cancer. Survivorship care addresses physical, emotional, psychological, and social challenges associated with cancer treatment and recovery. Research aims to improve rehabilitation, symptom management, and quality of life while promoting comprehensive patient-centred care. As survival rates continue to increase, survivorship research remains an essential component of modern oncology.
Emerging cancer research highlights innovative discoveries, technologies, and therapeutic approaches that are shaping the future of oncology. Areas of interest include artificial intelligence, next-generation sequencing, advanced immunotherapies, regenerative medicine, and digital health solutions. These advancements are transforming how cancer is detected, treated, and monitored. The exploration of emerging trends fosters scientific collaboration and accelerates the development of novel strategies to improve patient outcomes and advance global cancer care.
Market analysis
Cancer continues to be one of the most significant global health challenges, creating substantial demand for research, innovation, and collaboration among scientists, clinicians, healthcare providers, and industry stakeholders. The growing incidence of cancer worldwide has accelerated investments in oncology research, precision medicine, immunotherapy, diagnostics, and targeted therapeutics.
According to the World Health Organization and The International Agency for Research on Cancer, approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. Furthermore, more than 35 million new cancer cases are projected annually by 2050, representing a 77% increase compared to current levels.
The global oncology market is experiencing remarkable growth. Industry analysts estimate that the oncology market was valued at approximately USD 250 billion in 2025 and is expected to exceed USD 668 billion by 2034, growing at a compound annual growth rate (CAGR) of over 11.5%.
Additionally, worldwide oncology spending is projected to increase from approximately USD 295 billion in 2025 to more than USD 441 billion by 2029, reflecting the increasing adoption of innovative cancer therapies and diagnostic technologies.
Several rapidly expanding sectors are driving the oncology market, including:
- Precision Oncology and Personalized Medicine
- Cancer Genomics and Molecular Diagnostics
- Immunotherapy and Cancer Vaccines
- Artificial Intelligence in Oncology
- Liquid Biopsy Technologies
- Biomarker Discovery and Validation
- Cell and Gene Therapy
- Translational Cancer Research
- Early Detection and Cancer Screening
- Digital Health and Remote Patient Monitoring
Europe remains a leading centre for cancer research, supported by strong academic institutions, comprehensive cancer centres, biotechnology companies, and multinational pharmaceutical organizations. Spain, in particular, offers a strategic location for international scientific exchange, making Madrid an ideal destination for global oncology conferences.
The demand for specialized cancer conferences continues to grow as researchers seek opportunities to present findings, establish collaborations, and stay informed about emerging technologies and treatment paradigms. Conferences focusing on genomics, immunotherapy, precision medicine, and translational oncology consistently attract high participation from academia, healthcare institutions, pharmaceutical companies, biotechnology firms, regulatory agencies, and patient advocacy organizations.
Under the theme "Revolutionizing Cancer Research: Integrating Genomics, Immunotherapy, and Precision Medicine," Cancer Research 2026 is positioned to address the most influential trends shaping modern oncology. The conference will provide a dynamic platform for knowledge exchange, networking, and scientific advancement, contributing to the global effort to improve cancer prevention, diagnosis, treatment, and patient outcomes.
To Collaborate Scientific Professionals around the World
Conference Date October 05-06, 2026
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by